Coordination Pharmaceuticals, Inc.
Coordination Pharmaceuticals, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, malignant tumor of neck, neoplasm | Not yet recruiting | Phase 2 | 2026-07-29 | NCT07732634 | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | Head and Neck Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-09-17 | NCT05838729 |